Form 4: Erasca Inc. Director Acquires Stock Options

Director James Arthur Bristol acquired 29,888 stock options in Erasca Inc. (ERAS) on June 26, 2026, with vesting contingent on continued service.

Summary

• James Arthur Bristol, a Director at Erasca, Inc., acquired 29,888 stock options on June 26, 2026.
• These options have an exercise price of $16.01 and are exercisable starting June 26, 2027.
• The options expire on June 26, 2036.
• The vesting of 100% of these options is contingent upon Mr. Bristol's continuous service to Erasca, Inc. on June 26, 2027.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event; it's a standard stock option grant to a director, indicating continued engagement but not necessarily a significant positive or negative development on its own.

Positives

• Director James Arthur Bristol's acquisition of stock options indicates a continued commitment and potential belief in the company's future performance.
• The acquisition of options at a specific exercise price ($16.01) suggests a potential for future value creation if the stock price appreciates.

Risks

• The vesting of the stock options is contingent on the Reporting Person's continuous service, meaning failure to remain employed by the company could result in forfeiture of these options.
• The exercise price of $16.01 implies that the stock price needs to exceed this level for the options to be profitable.

Future Outlook

The future outlook for Erasca, Inc. is implicitly tied to the potential appreciation of its stock price above the $16.01 exercise price of the acquired options, which is contingent on the company's performance and Mr. Bristol's continued service.

Industry Context

StockSavvy.ai notes that insider option grants, especially to directors, are common in the biotechnology and pharmaceutical sectors like Erasca, Inc., often used as a long-term incentive to align management's interests with shareholders and encourage growth.

Stakeholder Impact

• Shareholders: The grant of options to a director can be seen as a positive alignment of interests, potentially driving future value if the stock price increases. However, it also represents potential future dilution if exercised.
• Employees: The continued service requirement for vesting may incentivize directors to remain with the company, contributing to stability.
• Management: The option grant serves as a performance-based incentive for the director.

Next Steps

• Monitor Erasca, Inc.'s stock performance relative to the $16.01 exercise price.
• Observe James Arthur Bristol's continued service to the company through June 26, 2027, for option vesting.

Key Dates

Keywords

Erasca Inc., ERAS, Form 4, Stock Options, Insider Trading, Beneficial Ownership, Director, Securities Exchange Act